Qingdainone
APC-1609
Qingdainone
Cat. No.
APC-1609
CAS No.
97457-31-3
MF
C23H13N3O2
MW
363.37
Qingdainone is a quinazoline alkaloid and also a TMPRSS2 inhibitor.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085 
info@aktin.com Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
97457-31-3
MF
C23H13N3O2
MW
363.37
Specification
98%
Research Area
Anti-inflammatory, antitumor
Description
Qingdainone is a quinazoline alkaloid and also a TMPRSS2 inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g Availability: In stock
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Li H, et al. Deciphering Key Pharmacological Pathways of Qingdai Acting on Chronic Myeloid Leukemia Using a Network Pharmacology-Based Strategy. Med Sci Monit. 2018 Aug 15;24:5668-5688.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1809
(-)-Curine
CAS No.:436-05-5
MF:C36H38N2O6
APC-1808
Fusicoccin from Fusicoccum amygdali
CAS No.:20108-30-9
MF:C36H56O12
APC-1806
Albine formate
CAS No.:53915-26-7(free base)
MF:C15H22N2O3
APC-1805
OSW-1
CAS No.:145075-81-6
MF:C47H68O15
APC-1804
Angustifoline formate
CAS No.:550-43-6（free base）
MF:C15H24N2O3
APC-1803
Aloe-emodin 8-O-β-D-(6'-galloyl)glucopyranoside
CAS No.:1374014-36-4
MF:C28H24O14
APC-1800
(+)-allo-Hydroxycitric acid calcium salt /Hibiscus acid calcium
CAS No.:27750-11-4 (free base)
MF: C12H10Ca3O16
APC-1799
Isoengeletin
CAS No.:30987-58-7
MF:C21H22O10
APC-1798
Isoastilbin
CAS No.:54081-48-0
MF:C21H22O11
APC-1797
(-)-3-Dehydroshikimic acid
CAS No.:2922-42-1
MF:C7H8O5
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
